Vitamin D receptor polymorphisms in immune thrombocytopenic purpura

Pediatr Int. 2017 Jun;59(6):682-685. doi: 10.1111/ped.13273. Epub 2017 May 16.

Abstract

Background: Vitamin D receptor (VDR) polymorphisms have been studied in immune-mediated disorders, but not yet in immune thrombocytopenic purpura (ITP). We investigated whether VDR variants were associated with ITP in children.

Methods: The study included 44 children with a diagnosis of ITP and 100 healthy controls. Five VDR polymorphisms (Cdx-2, FokI, BsmI, ApaI and TaqI) were genotyped and used to evaluate the association of VDR variants with ITP.

Results: The distribution of the three Cdx-2 genotype groups (GG, GA, and AA) was significantly different between ITP patients and controls (P = 0.025); the homozygous GG genotype of Cdx-2 was overrepresented in ITP patients. The frequency of the A allele of Cdx-2 was significantly different between patients and controls (P = 0.01). The A allele of Cdx-2 was associated with a decreased risk of ITP (OR, 0.343; 95% CI: 0.150-0.782). No statistically significant difference was found between the ITP group and control group for Fok1, Bsm1, Apa1, and Taq1 polymorphisms (P > 0.5).

Conclusion: There appears to be an interaction between the Cdx-2 variant of VDR and childhood immune thrombocytopenia.

Keywords: Vitamin D receptor; children; immune thrombocytopenic purpura; polymorphism.

MeSH terms

  • Adolescent
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Female
  • Genetic Markers
  • Genotype
  • Genotyping Techniques
  • Humans
  • Infant
  • Male
  • Polymorphism, Single Nucleotide*
  • Purpura, Thrombocytopenic, Idiopathic / genetics*
  • Receptors, Calcitriol / genetics*

Substances

  • Genetic Markers
  • Receptors, Calcitriol
  • VDR protein, human